Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Interim results

26th Aug 2010 07:00

RNS Number : 6580R
Huntsworth PLC
26 August 2010
 



On track for revenue growth of more than 7% during 2011

 

Huntsworth PLC

 

Interim results for the six months to 30 June 2010

 

Huntsworth PLC, the global public relations and healthcare communications group, today announces its interim results for the six months to 30 June 2010.

 

Financial highlights

 

Revenue

·; Revenue up to £87.0m (H1 '09: £76.5m)

·; Net new business wins of £26.5m up 11% on previous year

·; 89% of full year revenues committed for 2010

·; Like-for-like revenue growth of 0.4%

·; Global revenues up to 8% of group revenues

·; Multi office revenues up to 33% of group revenues

 

Profits

·; Operating profits increased by 25.6% to £13.6m (H1 '09: £10.9m)

·; Operating margin before central costs up to 20.6% (H1 '09: 19.4%)

·; Operating margin post central costs up to 15.7% (H1 '09: 14.2%)

·; Profit before tax up 9% to £12.0m (H1 '09: £11.0m)

·; Profit before tax after highlighted items up to £9.6m (H1 '09: £1.5m)

 

Basic earnings per share

·; Before highlighted items at 3.9p (H1 '09: 3.8p)

·; After highlighted items at 3.0p (H1 '09: 0.1p)

 

Cashflow and net debt

·; Cash flow from operating activities of £8.5m, representing a cash conversion of 63% (H1 '09: 72%)

·; Net debt at £55.9m (31 December 2009: £49.0m)

 

Other highlights

·; Interim dividend up 20% to 0.9p (H1 '09: 0.75p)

 

Notes:

1) All results are stated before taking account of highlighted items unless otherwise stated. These comprise amortisation of intangible assets in 2010. Highlighted items in 2009 comprise amortisation of intangibles, loss on disposal of subsidiaries, impairment of investment in associates, acquisition payments deemed as remuneration and net brand rationalisation and other non-recurring items.

2) Like-for-like revenues are stated at constant exchange rates and are adjusted to include pre-acquisition revenues and exclude disposals/closures.

3) In July 2010 Huntsworth acquired 100% of the share capital of ScopeMedical Limited a fast growing global medical communications company.

 

Peter Chadlington, Chief Executive of Huntsworth, said:

"The market is clearly more buoyant than 12 months ago and the outlook is generally more positive. While there are still economic uncertainties throughout the world, our major reorganisation last year is beginning to produce some very positive results and we have 89% of our full year revenues committed. We believe that we are on target to meet full year management expectations and to achieve more than 7% like-for-like revenue growth rates during 2011."

 

Contacts:

 

Huntsworth PLC +44 (0)207 224 8778

Peter Chadlington, Chief Executive

Sally Withey, Chief Operating Officer

 

Citigate Dewe Rogerson +44 (0)207 638 9571

Simon Rigby

George Cazenove

 

 

A presentation to analysts will take place at 9.30am on 26 August 2010 at the offices of Numis Securities Limited, 5th Floor, 10 Paternoster Square, London, EC4M 7LT.

 

 

CHIEF EXECUTIVE'S STATEMENT

 

Overview

 

I am pleased to report a set of robust results for the six months to 30 June 2010, in line with half year consensus forecasts. In the first half, revenues were up by 13.7% to £87.0 million and profits before tax and highlighted items, were up 9.0% to £12.0 million. Margins before central costs are 20.6% (ahead of 2009 at 19.4%) and post central cost margins are at 15.7% (2009:14.2%).

Three of the four Huntsworth divisions, which from today report separately, are now recording like-for-like revenue growth rates between 4% and 7%. Grayling, which was the prime vehicle of brand rationalisation last year, has its strongest ever new business pipeline and is expected to return to revenue growth during the second half as new international business wins come on stream. Overall, Huntsworth expects to meet its Group like-for-like revenue targets of more than 7% during 2011.

We have made good progress on our strategy to build a global and international business following last year's brand rationalisation and are pleased to report that global accounts have more than doubled, now representing 8% of Group revenues while multi-office clients are up 24% and now represent 33% of Group revenues.

The new Grayling brand, which was launched on 1 January 2010, has won as a direct result of the rebranding some £5 million of new international business and despite all the changes following the brand rationalisation, still achieved 19.6% operating margins. Underpinned by our success in securing international new business, Grayling is on course to return to revenue growth before the end of this year. This timetable for growth is supported by our experience with Huntsworth Health which was restructured with global capabilities three years ago and today reports like-for-like revenue growth of 7.1% with a significant increase in multi-million dollar international accounts.

Red continues to grow its business very successfully reporting like-for-like revenue growth of 5.0% while Citigate has delivered like-for-like revenue growth of 4.2%.

We now have four strong independent brands. Increased levels of co-operation across the group have resulted in some significant cross divisional success - notably a significant public relations win, the Qatar Financial Centre Authority for Citigate and Grayling and a major win for a top pharmaceutical company secured by Grayling and Huntsworth Health.

Our balance sheet remains strong with debt levels comfortably within our facilities and covenants. Cash conversion in the first half was 63% and we are on track to meet our annual cash conversion target of 100%.

The interim dividend has been increased by 20% as compared to 2009 to 0.9p.

 

Citigate

 

·; 15% of group revenues

·; Like-for-like revenue growth of 4.2%

·; 90% of full year revenues committed for 2010

·; Operating margins of 22.3%

·; Ranked fourth for global M&A, (source: mergermarkets) gaining market share in cross border transactions and advisory work

 

Citigate delivered a creditable performance in a market where transaction activity was muted and, although activity has increased around the globe, the IPO market in the UK was largely still on hold. However, Citigate was able to boost revenues by undertaking significant project work for existing clients. It also strengthened its position in the M&A market and was ranked fourth in the PR advisor league table for global M&A deals. It is therefore well placed to benefit from any further upturn in activity.

Client wins in the first half include the Qatar Financial Centre Authority (QFCA), easyGroup, PetroNeft Resources plc and Chaucer. QFCA is a global account managed by Citigate and Grayling offices across Europe, the Middle East and Asia.

Citigate advised on a number of transactions including the £1.32 billion acquisition of VT Group plc by Babcock International Group plc, the acquisition of Scott Wilson Group plc by URS Corporation and the $1.35 billion acquisition of Heritage Oil's Ugandan assets by Tullow Oil plc. It also advised Warburg Pincus on its purchase of both Poundland and Survitec Group Ltd, and on the IPO's of OAO Protek, Russia's biggest since 2007, Russian Sea Group and LBi, Europe's largest marketing and technology agency.

Citigate won some significant corporate retainers including Schroders, May Gurney, Foreign Currency Direct, GSK Consumer Healthcare (Corsodyl), Western Gulf Advisory and Direct Line.

As well as winning new mandates, Citigate has maintained healthy margins by keeping tight control of existing retainer income whilst maintaining an active project pipeline. It has also extended the range of services it offers, particularly in the areas of internal communications and digital crisis management, matching its expertise to the current needs of its clients.

 

Grayling

 

·; 48% of group revenues

·; Like-for-like revenue decline of 4.9%

·; £5m of international/global business won from new clients on an annualised basis

·; Largest ever pipeline of international opportunities

·; Network business up from 7% to 10% of Group revenues

·; Expanded remits received from 11 of our top 15 clients

·; Over €10m of EU tender opportunities

·; 89% of full year revenues committed for 2010

·; Operating margins at 19.6%

 

Grayling, which comprises 48% of group revenue established a unifying global brand in January 2010. This significant rationalisation will take time to develop fully but already we have rationalised the management team, made strategic investments in new capabilities and are building a global culture. Our focussed approach includes targeting global and international clients, increasing remits from existing clients and expanding our digital capabilities. Operating margins in the division were strong at 19.6% despite increased pitch activity, a number of investments in senior hires and the creation of a global new business team.

We saw a like-for-like revenue decline of 4.9% in the first six months of 2010, primarily caused by the loss or resignation of commodity business in Grayling and Dutko as we move our focus onto new revenue streams with greater growth potential. Grayling was also affected by the difficult but improving economic environment in Continental Europe.

Grayling has won £5 million of annualised revenues which it would not have been considered for prior to the rebranding, demonstrating an impressive 45% pitch conversion rate. These include Nabucco, Apcor, Aviva, The Critical National Infrastructure Authority, Economist Intelligence Unit, Wolf Theiss, Qatar Financial Centre Authority and the Singapore Government.

The division's new capabilities have also helped Grayling to grow 11 of its top 15 clients by an average of 58%. Expanded remits include Chevron, Land Rover, Skype, Reckitt Benckiser, Netviewer and Doro.

These new revenue streams are larger in size than our historical fees and we saw an increase in average fees per client of 7% to £56,000. Retainer revenues increased to 67% of the divisional total.

Our ability to increase fees per client has been significantly strengthened via the strategic acquisition of Dutko in December 2009. Dutko has given us a stronger presence in the United States and allows us to give our clients insight into the US political landscape which is an important element to securing new international revenue streams. Wins which cover both public relations and federal government relations include Council of Naima, Integra and General Motors.

New business wins in recent weeks have been encouraging with net new business wins for the first six months up 9% on 2009. Progress is underpinned by Grayling's strongest ever new business pipeline which currently includes a number of substantial international opportunities at various stages of development. Grayling has also submitted EU global tenders worth a total value of over €10 million. With 89% of forecast full year revenues committed for 2010, Grayling is on track to return to revenue growth in the second half of this year.

 

 

Huntsworth Health

 

·; 29% of group revenues

·; Like-for-like revenue growth of 7.1%

·; 3 global accounts each delivering over £3m of annual revenues

·; Largest ever medical communications win, $3m with Novartis

·; Largest ever sales training win with Johnson & Johnson for more than $1mDigital growth of 36%

·; 88% of full year revenues committed for 2010

·; Operating margins of 20.8%

 

Huntsworth Health was established as a global brand in 2007 and now has offices in the US, UK, and Asia as well as access to Continental Europe via the Grayling network. The new global structure allowed Huntsworth Health to establish business relationships with 39 of the top 50 pharmaceutical companies and average fee revenue per client across those 39 companies is now greater than £850,000.

 

'Preferred Provider' status has increased to eight major pharmaceutical companies, up from five when we announced our full year 2009 results with three further major contracts under review.

 

When we announced our 2009 results, we had two clients delivering over £3 million of revenues. This has increased to three clients in 2010 with one of those clients now awarding us in excess of $7 million of fee revenue on one of the world's top 10 brands.

Our growth is underpinned by strong digital revenues (up 36%) which have come from the expansion of existing client relationships as well as new client wins.

 

New business wins of note in the first half include a multi-million dollar win at Novartis, the largest sales training contract ever signed at Johnson & Johnson for more than $1 million and a large global medical communications project at Pfizer.

 

New business momentum is very strong with identified new business that has been submitted or in preparation, more than double than at this point in 2009. ScopeMedical, the international medical communications agency acquired in July has successfully integrated into the group providing Huntsworth Health with access to four new global clients that we have not previously worked with.

 

Red

 

·; 8% of group revenues

·; Like-for-like revenue growth of 5.0%

·; 93% of full year revenues committed for 2010

·; Operating margins of 21.9%

·; Public sector losses offset by strong new wins

 

Red grew again in the first six months of the year after very strong growth in 2009. Wins included Avis, Barclaycard, alli, Kelkoo, Tommee Tippee, Coca Cola, Thistle and Adobe.

Notable campaigns included rolling out a counterfeit medicine campaign across 14 European countries for Pfizer; continuing to create award-winning global programmes for McAfee; digitally-led PR campaigns for Cobra; and supporting Santander's rebrand of Alliance & Leicester with a nationwide community programme.

Committed revenues for 2010 are strong at 93% despite the loss of UK public sector work which previously accounted for approximately 10% of revenues.

Group Outlook

 

Our major reorganisation last year is beginning to produce some very positive results. We believe that we are on target to meet full year management expectations and to achieve more than 7% like-for-like revenue growth rates during 2011. There is still a lot to do but the pipelines are strong and there are much higher levels of multi-brand revenues across the Group.

 

 

To view an interview with Lord Chadlington and Sally Withey on the interim results following last year's brand rationalisation programme, and the outlook for Huntsworth, please view the following link:

 

http://www.huntsworth.co.uk/investors.aspxI 

 

REVIEW OF FINANCIAL RESULTS

 

SUMMARY OF FINANCIAL RESULTS

 

 

2010

Like-for-like growth

2009

£'m

£'m

Revenue

Citigate

13.5

4.2%

13.1

Grayling

41.8

(4.9)%

34.6

Huntsworth Health

25.1

7.1%

22.3

Red

6.7

5.0%

6.6

Eliminations

(0.1)

(0.1)

Total operations

87.0

0.4%

76.5

Operating profit

Margin

Margin

Citigate

3.0

22.3%

2.9

22.4%

Grayling

8.2

19.6%

6.4

18.4%

Huntsworth Health

5.2

20.8%

4.0

17.9%

Red

1.5

21.9%

1.6

23.7%

Total operations

17.9

20.6%

14.9

19.4%

Central costs

(4.3)

(4.0)

Profit before highlighted items

13.6

15.7%

10.9

14.2%

Operating highlighted items

(2.4)

(8.3)

Reported operating profit

11.2

2.6

Adjusted basic EPS

3.9p

3.8p

Reported basic EPS

3.0p

0.1p

Introduction

 

In the commentary below all results are stated before taking account of highlighted items unless otherwise stated. Highlighted items in 2010 comprise amortisation of intangible assets only. Highlighted items in 2009 comprise amortisation of intangibles, loss on disposal of subsidiaries, impairment of investment in associates, acquisition payments deemed as remuneration and net brand rationalisation and other non-recurring items.

 

Like-for-like growth is based on revenues at constant exchange rates, adjusted to include pre-acquisition revenues and exclude disposals/closures.

 

Revenue and profits

 

Group revenue in the six months to 30 June 2010 increased by 13.7% to £87.0 million (H1 2009: £76.5 million).

 

On a like-for-like basis, revenues grew in three of our four divisions with Huntsworth Health at 7.1%, Red at 5.0% and Citigate at 4.2%. Grayling, which saw the main impact of the brand rationalisation at the end of last year saw a like-for-like revenue decline of 4.9% but maintained strong margins and is expected to return to revenue growth before the end of this year. Overall like-for-like revenue grew by 0.4% in the first half of the year.

 

Group operating profits before central costs in the first half increased by 20.4% to £17.9 million (H1 2009: £14.9 million) and the Group has continued to deliver strong margins. Group operating margin before central costs was 20.6% (H1 2009: 19.4%) with divisional margins ranging between 19.6% (Grayling) and 22.3% (Citigate). Operating margin after central costs was 15.7%, up from 14.2% in the first half of 2009.

 

Underlying margins adjusted for charges not repeated in the second half (holiday pay and US payroll taxes) were 21.7% pre central costs and 16.9% after central costs.

 

Operating profit after central costs for the period increased by 25.5% to £13.6 million (H1 2009: £10.9 million).

 

Profit before tax was up 9% at £12.0 million (H1 2009: £11.0 million).

Currency

Changes in exchanges rates have had very little impact on the Group's results in the period.

Highlighted items

Operating highlighted items of £2.4 million in the first half of 2010 relate to the amortisation of intangible assets (H1 2009: total operating highlighted items £8.3 million).

 

After highlighted items, statutory reported operating profit was £11.2 million (H1 2009: £2.6 million).

Tax

The tax charge of £2.5 million comprises an underlying tax charge of £2.8 million together with a credit of £0.3 million on highlighted items. The underlying tax charge is based on the expected full year underlying tax rate of 23% (year ended 31 December 2009: 25.5%).

Earnings

Profits attributable to ordinary shareholders were £9.2 million (H1 2009: £7.8 million). Profits after highlighted items attributable to ordinary shareholders amounted to £7.1 million (H1 2009: £0.2 million).

 

Basic earnings per share were 3.9p (H1 2009: 3.8p). Diluted earnings per share were 3.8p (H1 2009: 3.7p). Basic earnings per share after highlighted items were 3.0p (H1 2009: 0.1p).

 

Dividends

The Board has continued its progressive dividend policy. The interim dividend has been increased by 20% to 0.9p per share (H1 2009: 0.75p). The record date for this dividend will be 1 October 2010 and it is payable on 5 November 2010. A scrip dividend alternative will be available.

Balance sheet and cash flow

The Group remains in a strong financial position and our businesses continue to generate good operating cash flows.

 

Net debt at 30 June 2010 was £55.9 million (31 December 2009: £39.9 million), well within the Group's debt facilities.

 

Cash inflow from operations amounted to £8.5 million (H1 2009: £7.8 million). This was before a £3.1 million cash impact relating to prior periods highlighted items. Cash conversion of operating profit into operating cash flows was 63%, in line with normal levels at the half year. For the full year, Huntsworth expects cash conversion to achieve the Group's minimum target of 100%.

 

Other principal cash flows during the period were net payments for interest, tax and fixed assets of £4.0 million, purchase of shares through the buyback programme of £1.1 million and a net outflow in respect of acquisitions of £6.7 million.

 

The Group continues to operate well within its banking covenants and facilities which comprise a revolving credit facility and a committed overdraft totalling £87.0 million continuing until 2011 and decreasing to £82.5 million until September 2012 as a term loan is repaid. Net debt to EBITDA was at a ratio of 1.7 times at 30 June 2010 and interest cover (excluding highlighted items and imputed interest) was 14 times (H1 2009: 8 times).

Earn-out payments

Future contingent earn-out payments as at 30 June 2010 are estimated at £30.5 million, comprising £24.2 million payable in cash and £6.3 million payable in cash/shares at Huntsworth's option. The timing of the aggregate of these payments is £3.0 million in 2010, £17.5 million in 2011 (when the final payments are due in relation to the purchase of Axis), £2.8 million in 2012 and £7.2 million in 2013.

 

Key risks and uncertainties

 

As detailed on page 19 of the 2009 Annual Report and Accounts, the Group's key risks and uncertainties are identified as: dependence on key personnel and relationships with clients; management of growth; failure of information systems; competition in the provision of services; fluctuations of revenues, expenses and operating results; currency rate risk; and exposure to a downturn in the public relations industry. These risks are not considered to have changed since the 2009 Annual Report and Accounts were published.

 

Forward looking statements

 

The interim management report contains certain forward looking statements in respect of Huntsworth plc and the operation of its subsidiaries. These statements and forecasts involve risk and uncertainty because they relate to events and depend upon circumstances that may or may not occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward looking statements and forecasts. Nothing in this announcement should be construed as a profit forecast.

 

 

Notes to Editors:

 

1. Huntsworth PLC is a global public relations and healthcare communications group with 70 principal offices in 31 countries and 2,080 clients.

2. At 30 June the Group employed approximately 1,630 staff with an average annual fee income per head of £107,000.

3. Group revenue comprises the following key areas of activity: Corporate Communications and Public Affairs account for 35% of Group revenue; Consumer and B2B work account for 17% of Group Revenue; Financial non-deal led Public Relations work is 12%; Financial deal led Public Relations is 2%; Huntsworth Health is 29% and other activities are 5%.

4. By industry sector the revenue profile is broadly 29% Pharmaceuticals; 11% Financial Services; 8% Government & Public Sector; 7% Technology; 6% Retail & Leisure; 6% Healthcare; 5% Food and Drink and 5% Industrial.

5. Geographically, 40% of Group revenue in the first half of 2010 was from the UK; 21% from other European countries; 35% from the US; and 4% from the Rest of the World.

6. As at August 2010 shareholdings of Directors, employees and employee trusts represent approximately 10% of the Group's issued share capital. Institutional shareholdings hold approximately 77%, with the top 10 holding some 60% as of 11 August 2010.

 

 

Unaudited Consolidated Income Statement

for the six months ended 30 June 2010

 

 

 

 

 

 

 

 

Audited

 

 

 

Six months

Six months

Year

 

 

 

ended

ended

ended

 

 

 

30 June

30 June

31 December

 

 

 

2010

2009

2009

 

 

Notes

£000

£000

£000

Turnover

 

111,615

100,280

209,033

 

 

 

 

 

Revenue

3

86,993

76,513

156,319

Operating expenses - excluding highlighted items

 

(73,365)

(65,659)

(133,119)

Operating expenses - highlighted items

 

(2,462)

(8,300)

(31,109)

Operating expenses - total

 

(75,827)

(73,959)

(164,228)

Operating profit before highlighted items

3

13,628

10,854

23,200

Highlighted items - operating expenses

4

(2,462)

(8,300)

(31,109)

Operating profit/(loss)

 

11,166

2,554

(7,909)

Share of post-tax profit of associates

 

-

1,285

2,095

Highlighted item - impairment of associates

4

-

(1,285)

(2,095)

Finance income

5

15

267

260

Finance costs

5

(1,606)

(1,366)

(2,190)

Profit before tax and highlighted items

 

12,037

11,040

23,365

Highlighted items

4

(2,462)

(9,585)

(33,204)

Profit/(loss) before tax

 

9,575

1,455

(9,839)

Taxation (expense)/credit

6

(2,456)

(1,221)

1,246

Profit/(loss) for the period

 

7,119

234

(8,593)

 

 

 

 

 

Attributable to:

 

 

 

 

Parent Company's equity shareholders

 

7,079

193

(8,648)

Non-controlling interests

 

40

41

55

 

 

7,119

234

(8,593)

Earnings/(loss) per share:

 

 

 

 

Basic - pence

8

3.0

0.1

(4.2)

Diluted - pence

8

2.9

0.1

(4.2)

Adjusted basic - pence*

8

3.9

3.8

8.2

Adjusted diluted - pence*

8

3.8

3.7

8.0

*Adjusted basic and diluted earnings per share are calculated based on the profit/(loss) for the period adjusted for highlighted items and the related tax effects (Note 8).

 

 

 

Unaudited Consolidated Statement of Comprehensive Income and Expense

for the six months ended 30 June 2010

 

 

 

 

Six months

 ended

Six months

 ended

Audited Year

 ended

 

 

30 June

30 June

31 December

 

 

2010

2009

2009

 

 

£000

£000

£000

 

Profit/(loss) for the period

7,119

234

(8,593)

 

 

 

 

 

 

Other comprehensive income/(expense)

 

 

 

 

Movement in valuation of interest rate swaps

(499)

(31)

(264)

 

Tax credit on interest rate swaps

140

-

74

 

Currency translation differences

3,179

(16,182)

(11,726)

 

Tax credit/(expense) on currency translation reserve

163

(288)

(136)

 

Other comprehensive income/(expense) for the period

2,983

(16,501)

(12,052)

 

 

 

 

 

 

Total comprehensive income/(expense) for the period

10,102

(16,267)

(20,645)

 

 

 

 

 

 

Total comprehensive income/(expense) attributable to:

 

 

 

 

-Parent Company's equity shareholders

10,062

(16,308)

(20,700)

 

-Non-controlling interests

40

41

55

 

 

10,102

(16,267)

(20,645)

 

 

 

 

 

Audited

 

 

30 June

30 June

31 December

 

 

2010

2009

2009

 

Notes

£000

£000

£000

Non-current assets

 

 

 

 

Intangible assets

9

290,243

250,232

287,264

Property, plant and equipment

 

4,952

4,854

4,933

Investment in associates

 

52

1,845

59

Other non-current financial assets

 

104

-

104

Other receivables

 

336

-

470

Derivative financial assets

10(c)

6

96

71

Deferred tax assets

 

5,696

2,693

5,469

 

 

301,389

259,720

298,370

Current assets

 

 

 

 

Work in progress

 

1,890

1,345

1,472

Trade and other receivables

 

44,526

40,422

45,929

Corporation tax receivable

 

1,333

1,918

917

Derivative financial assets

10(c)

157

366

304

Cash and short-term deposits

10(d)

8,731

6,848

9,394

 

 

56,637

50,899

58,016

Current liabilities

 

 

 

 

Bank loans and overdrafts

10(c)

(3,004)

(11)

(3,023)

Obligations under finance leases

10(c)

(68)

(140)

(59)

Trade and other payables

 

(49,750)

 (45,891)

(53,750)

Derivative financial liabilities

10(c)

(92)

-

(92)

Corporation tax payable

 

(6,155)

 (6,395)

(6,086)

Provisions

 

(20,621)

 (11,878)

(10,792)

 

 

(79,690)

 (64,315)

(73,802)

Non-current liabilities

 

 

 

 

Bank loans and overdrafts

10(c)

(60,068)

(46,071)

(54,550)

Obligations under finance leases

10(c)

(89)

(133)

(88)

Provisions

 

(14,425)

 (16,046)

(28,092)

Trade and other payables

 

(468)

 (263)

(417)

Derivative financial liabilities

10(c)

(1,489)

(849)

(990)

Deferred tax liabilities

 

(5,349)

 (3,001)

(4,309)

 

 

(81,888)

 (66,363)

(88,446)

Net assets

 

196,448

179,941

194,138

Equity

 

 

 

 

Called up share capital

 

106,233

106,006

106,233

Shares to be issued

 

6,921

-

6,921

Share premium account

 

24,763

23,760

24,763

Merger reserve

 

56,506

51,122

56,506

Foreign currency translation reserve

 

24,732

 17,097

21,553

Hedging reserve

 

(1,515)

(783)

(1,016)

Treasury shares

 

(3,657)

(676)

(2,654)

Investment in own shares

 

(4,195)

 (6,073)

(4,446)

Retained earnings

 

(13,700)

 (11,537)

(14,752)

Equity attributable to equity holders of the parent

 

196,088

178,916

193,108

Non-controlling interests

 

360

1,025

1,030

Total equity

 

196,448

179,941

194,138

 

 

Unaudited Consolidated Statement of Cash Flows

for the six months ended 30 June 2010

 

 

 

 

 

Audited

 

 

Six months

Six months

Year

 

 

ended

 ended

ended

 

 

30 June

30 June

31 December

 

 

2010

2009

2009

 

Notes

£000

£000

£000

Cash inflow from operating activities

 

 

 

 

Cash inflow from operations

10(a)

5,470

2,596

17,962

Interest paid

 

(1,246)

(966)

(1,689)

Interest received

 

15

223

242

Net cash flows from hedging activities

 

4

-

(497)

Corporation tax paid

 

(1,746)

 (993)

(2,555)

Net cash inflow from operating activities

 

2,497

 860

13,463

Cash outflow from investing activities

 

 

 

 

Acquisition of subsidiaries, net of cash acquired

 

(4,544)

 (3,481)

(11,654)

Proceeds on sale and liquidation of subsidiaries, net of cash disposed

 

-

(375)

(1,402)

Acquisition of non-controlling interests

 

(2,146)

(315)

(315)

Cost of internally developed intangible assets

 

(90)

(168)

(186)

Purchase of non-current financial assets

 

-

-

(104)

Purchases of property, plant and equipment

 

(1,025)

 (758)

(1,697)

Proceeds from sale of property, plant and equipment

 

26

-

46

Dividends received from associates

 

-

1,642

3,470

Net cash outflow from investing activities

 

(7,779)

 (3,455)

(11,842)

Cash inflow/(outflow) from financing activities

 

 

 

 

Purchase of own shares - investment in own shares

 

-

 (1,453)

(1,499)

Purchase of own shares - treasury shares

 

(1,061)

(676)

(3,168)

Repayment of finance lease liabilities

 

(39)

 (24)

(151)

Net drawdown of borrowings

 

5,395

49

4,654

Dividends paid to non-controlling interests

 

-

(11)

(20)

Dividends paid to equity holders of the parent

 

-

-

(4,579)

Net cash inflow/(outflow) from financing activities

 

4,295

(2,115)

(4,763)

Decrease in cash and cash equivalents

 

(987)

 (4,710)

(3,142)

Movements in cash and cash equivalents

 

 

 

 

Decrease in cash and cash equivalents

 

(987)

(4,710)

(3,142)

Effects of exchange rate fluctuations on cash held

 

343

(2,227)

(1,261)

Cash and cash equivalents at 1 January

 

9,371

13,774

13,774

Cash and cash equivalents at end of period

10(c), (d)

8,727

6,837

9,371

 

 

Unaudited Consolidated Statement of Changes in Equity

for the six months ended 30 June 2010

 

Called

Foreign

up

Shares

Share

currency

Investment

Non-

share

to be

premium

Merger

translation

Hedging

Treasury

in own

Retained

controlling

Total

capital

issued

account

reserve

reserve

reserve

shares

shares

earnings

Total

interests

Equity

£000

£000

£000

£000

£000

£000

£000

£000

£000

£000

£000

£000

At 1 January 2009

106,006

-

23,760

51,122

33,279

(752)

-

(5,965)

(8,196)

199,254

999

200,253

Total comprehensive income for the period

-

-

-

-

(16,182)

(31)

-

-

(95)

(16,308)

41

(16,267)

Acquisition of non-controlling interests

-

-

-

-

-

-

-

-

-

-

(4)

(4)

Purchase of own shares

-

-

-

-

-

-

(676)

(1,177)

-

(1,853)

-

(1,853)

Settlement of share options

-

-

-

-

-

-

-

1,069

(592)

477

-

477

Credit for share-based payments

-

-

-

-

-

-

-

-

1,427

1,427

-

1,427

Equity dividends

-

-

-

-

-

-

-

-

(4,081)

(4,081)

-

(4,081)

Dividends to non-controlling interests

-

-

-

-

-

-

-

-

-

-

(11)

(11)

Balance at 30 June 2009

106,006

-

23,760

51,122

17,097

(783)

(676)

(6,073)

(11,537)

178,916

1,025

179,941

Total comprehensive income for the period

-

-

-

-

4,456

(233)

-

-

(8,615)

(4,392)

14

(4,378)

Acquisitions of subsidiaries

210

6,921

-

13,241

-

-

-

-

-

20,372

-

20,372

Purchase of own shares

-

-

-

-

-

-

(2,492)

-

-

(2,492)

-

(2,492)

Settlement of share options

-

-

-

-

-

-

-

2,141

(2,029)

112

-

112

Credit for share-based payments

-

-

-

-

-

-

-

-

1,109

1,109

-

1,109

Share issue costs

-

-

(9)

(10)

-

-

-

-

-

(19)

-

(19)

Scrip dividend

17

-

1,012

-

-

-

-

-

-

1,029

-

1,029

Equity dividends

-

-

-

-

-

-

-

-

(1,527)

(1,527)

-

(1,527)

Dividends to non-controlling interests

-

-

-

-

-

-

-

-

-

-

(9)

(9)

Transfers

-

-

-

(7,847)

-

-

514

(514)

7,847

-

-

-

Balance at 31 December 2009 (audited)

106,233

6,921

24,763

56,506

21,553

(1,016)

(2,654)

(4,446)

(14,752)

193,108

1,030

194,138

Total comprehensive income for the period

-

-

-

-

3,179

(499)

-

-

7,382

10,062

40

10,102

Acquisition of non-controlling interests

-

-

-

-

-

-

-

-

(1,436)

(1,436)

(710)

(2,146)

Purchase of own shares

-

-

-

-

-

-

(1,061)

-

-

(1,061)

-

(1,061)

Settlement of share options

-

-

-

-

-

-

58

251

(152)

157

-

157

Credit for share-based payments

-

-

-

-

-

-

-

-

60

60

-

60

Equity dividends

-

-

-

-

-

-

-

-

(4,802)

(4,802)

-

(4,802)

Balance at 30 June 2010

106,233

6,921

24,763

56,506

24,732

(1,515)

(3,657)

(4,195)

(13,700)

196,088

360

196,448

 

 

Notes to the Financial Statements

for the six months ended 30 June 2010

 

 

1. Basis of preparation

These consolidated interim financial statements, which are condensed and unaudited for the six months ended 30 June 2010, have been prepared in accordance with the Listing Rules of the Financial Services Authority. They have been prepared in accordance with the accounting policies which the Group expects to adopt in its 2010 Annual Report and are consistent with the policies which the Group adopted in the consolidated financial statements for the year ended 31 December 2009, except as noted below. These accounting policies are based on the EU-adopted International Financial Reporting Standards (IFRS) and International Financial Reporting Interpretations Committee (IFRIC) interpretations that the Group expects to be applicable at that time.

The consolidated interim financial statements for the six months ended 30 June 2010 have been prepared in accordance with the Disclosure and Transparency Rules of the Financial Services Authority and with IAS 34, Interim Financial Reporting, as adopted by the EU and under the historical cost convention, as modified by the revaluation of derivative financial instruments at fair value.

The information relating to the six months ended 30 June 2010 and 30 June 2009 is unaudited and does not constitute statutory financial statements as defined in Section 435 of the Companies Act 2006. They have however been reviewed by the auditors and their report to the Board of Huntsworth plc is set out on page 26 of this document. The comparative figures for the year ended 31 December 2009 have been extracted from the Group Report and Accounts, on which the auditors gave an unqualified opinion and did not include a statement under section 498 (2) or (3) of the Companies Act 2006. The Group Report and Accounts for the year ended 31 December 2009 have been filed with the Registrar of Companies.

 

The following new standards and amendments to standards are mandatory for the first time for the financial year beginning 1 January 2010:

IFRS 3 'Business Combinations' (revised 2008) makes significant changes to the treatment of acquisition costs and deferred contingent consideration relating to an acquisition. The revised standard has been applied prospectively to business combinations for which the acquisition date is on or after 1 January 2010. As a consequence of the adoption of this standard, all acquisition related transaction costs are now recorded in the income statement as highlighted items. Contingent consideration relating to acquisitions is measured at fair value at the acquisition date; any subsequent revisions to these estimates will be recorded in the income statement as highlighted items.

IAS 27 'Consolidated and Separate Financial Statements' (revised 2008) no longer restricts the allocation to non-controlling interests of losses incurred by a subsidiary to the amount of the non-controlling equity investment in the subsidiary. Any partial acquisition or disposal of equity interest in a subsidiary that does not result in a gain or loss of control will be accounted for as an equity transaction and will not impact goodwill or give rise to any gain or loss. This change has resulted in a reduction in equity of £1,436,000 in the period which would previously have increased goodwill.

The following new standards, amendments to standards and interpretations are mandatory for the first time for the financial year beginning 1 January 2010, but have no impact on the Group:

·; IFRS 2 (amendments) - Share based payments (effective for accounting periods beginning on or after 1 January 2010) ;

·; IFRS 5 (amendment) - Non-Current Assets Held for Sale and Discontinued Operations (effective for accounting periods beginning on or after 1 January 2010) ;

·; IAS 39 (amendment) - Financial Instruments: Recognition and Measurement (effective for accounting periods beginning on or after 1 July 2009);

·; IFRIC 17 - Distributions of non-cash assets to owners (effective for accounting periods beginning on or after 1 July 2009) ;

·; IFRIC 18 - Transfers of assets from customers (effective for accounting periods beginning on or after 1 July 2009).

 

Operating segments

As a result of the strategic branding initiative completed in January 2010, the Group has amended its operating segments in order to align them to the new group structure. The Group now has four operating segments - Grayling, Red, Citigate and Huntsworth Health. The new segments reflect the way in which the chief operating decision maker evaluates performance and decides how to allocate resources. The 2009 comparative data has been restated into the new segments.

 

Going concern

After reviewing the Group's performance and future cash flows, the Directors consider that the Group has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the Group's financial statements

 

  

2. Acquisitions

(i) Grayling International non-controlling interest

On 30 March 2010 and 15 April 2010, the Group purchased the remaining 10% stake of the issued share capital of Grayling International Limited in two tranches taking the total ownership interest to 100%. The total cash consideration was £2,066,700.

 

(ii) Shiny Red non-controlling interest

On 12 February 2010 the Group purchased the remaining 25% stake of the issued share capital of Shiny Red Limited for cash consideration of £78,900 taking the total ownership interest to 100%.

 

3. Segmental analysis

Business segments

The following is an analysis of the Group's revenue and operating profit before highlighted items by reportable segment. The prior year comparative data has been restated as discussed in Note 1.

 

Huntsworth

Citigate

Grayling

Red

Health

Total

6 months to 30 June 2010

£000

£000

£000

£000

£000

Revenue

Total revenue

13,535

41,826

6,713

25,032

87,106

Intra-group eliminations

(53)

(60)

-

-

(113)

Segment revenue

13,482

41,766

6,713

25,032

86,993

Segment operating profit before highlighted items

3,012

8,180

1,473

5,217

17,882

 

Huntsworth

Citigate

Grayling

Red

Health

Total

6 months to 30 June 2009 - Restated

£000

£000

£000

£000

£000

Revenue

Total revenue

13,096

34,590

6,647

22,254

76,587

Intra-group eliminations

(67)

-

-

(7)

(74)

Segment revenue

13,029

34,590

6,647

22,247

76,513

Segment operating profit before highlighted items

2,932

6,367

1,576

3,976

14,851

 

 

 

Huntsworth

Citigate

Grayling

Red

Health

Total

 

Year ended 31 December 2009 - Restated

£000

£000

£000

£000

£000

 

Revenue

 

Total revenue

27,450

70,029

13,161

45,790

156,430

 

Intra-group eliminations

(111)

-

-

-

(111)

 

Segment revenue

27,339

70,029

13,161

45,790

156,319

 

 

Segment operating profit before highlighted items

6,632

13,001

2,607

9,581

31,821

 

 

 

A reconciliation of segment operating profit before highlighted items to profit before tax is provided below:

 

 

Six months

Six months

Year

ended

ended

ended

30 June

30 June

31 December

2010

 2009

2009

£000

£000

£000

Segment operating profit before highlighted items

17,882

14,851

31,821

Unallocated costs

(4,254)

(3,997)

(8,621)

Operating profit before highlighted items

13,628

10,854

23,200

Highlighted items

(2,462)

(8,300)

(31,109)

Operating profit/(loss)

11,166

2,554

(7,909)

Share of profit of associates

-

1,285

2,095

Highlighted items - impairment of investment in associates

-

(1,285)

(2,095)

Net finance costs

(1,591)

(1,099)

(1,930)

Profit/(loss) before tax

9,575

1,455

(9,839)

 

 

4. Highlighted items

 

 

Six months

Six months

Year

 

ended

ended

ended

 

30 June

30 June

31 December

 

2010

2009

2009

 

£000

£000

£000

Charged to operating profit

 

 

 

Amortisation of intangible assets

2,462

2,387

4,770

Impairment of intangible assets

-

-

9,141

Loss on disposal and liquidation of subsidiaries

-

140

7,527

Acquisition payments to employees deemed to be remuneration

-

451

827

Net brand rationalisation and other non-recurring costs

-

5,322

8,844

 

2,462

8,300

31,109

Charged to profit before tax

 

 

 

Impairment of investment in associates

-

1,285

2,095

 

2,462

9,585

33,204

 

Highlighted items charged to profit before tax comprise significant non-cash charges and non-recurring items which are highlighted in the income statement because, in the opinion of the Directors, separate disclosure is helpful in understanding the underlying performance of the business.

 

Amortisation of intangible assets

Intangible assets are amortised systematically over their estimated useful lives, which vary from 3 to 20 years depending on the nature of the asset. These are significant non-cash charges which arise as a result of acquisitions.

 

Impairment of intangible assets

The impairment of intangible assets in 2009 comprised £9.1 million relating to brands. As a result of the brand rationalisation initiative, brands which were no longer used were impaired to nil carrying value.

 

Loss on disposal and liquidation of subsidiaries

The loss in 2009 principally related to the liquidation of the Group's operations in Italy and comprised £5.8 million of goodwill and other asset impairments and £1.7 million of cash cost.

 

Acquisition payments to employees deemed to be remuneration

Certain payments of consideration to non-shareholding employees of acquired businesses under arrangements set up prior to acquisition are deemed to be remuneration in the post-acquisition period. These costs ceased once the relevant earn-out was settled during 2009.

 

Net brand rationalisation and other non-recurring costs

As a result of the strategic rebranding initiative, costs of £8.8 million were incurred in 2009. This charge comprised £1.3 million of rebranding, £6.0 million of severance costs and £1.5 million of property costs relating to restructuring of teams and offices to align to the new structure.

 

Impairment of investment in associates

On 15 February 2006 the Company announced that it had reached an agreement to sell Citigate Sard Verbinnen ('CSV') by the end of December 2009 for a fixed amount. Following the sale of the initial 51% in 2007, the Group's investment in CSV was accounted for as an associate. All profits recognised from the date of the initial disposal until the disposal of the final 49% in December 2009 were matched by an equal and opposite impairment of the Group's investment in the entity.

 

 

5. Finance costs and income

 

 

Six months

Six months

Year

 

ended

ended

ended

 

30 June

30 June

31 December

 

2010

 2009

2009

 

£000

£000

£000

Bank interest payable

1,272

940

1,768

Finance lease interest

9

15

26

Fair value movement on financial instruments

65

-

-

Imputed interest on property provisions

45

80

64

Imputed interest on deferred consideration

215

331

332

Finance costs

1,606

1,366

2,190

Bank interest receivable

(12)

 (24)

(73)

Fair value movement on financial instruments

-

(44)

(169)

Other interest receivable

(3)

(199)

(18)

Finance income

(15)

(267)

(260)

Net finance costs

1,591

1,099

1,930

 

6. Taxation

The tax charge/(credit) for the six months ended 30 June 2010 has been based on an estimated effective tax rate on profit before highlighted items for the full year of 23.0% (year ended 31 December 2009: 25.5%). The tax charge/(credit) is analysed as follows:

 

 

Six months

Six months

Year

 

ended

ended

ended

 

30 June

30 June

31 December

 

2010

2009

2009

 

£000

£000

£000

Before highlighted items:

 

 

 

Current tax

1,704

2,480

4,548

Deferred tax

1,065

609

1,410

 

2,769

3,089

5,958

Highlighted items:

 

 

 

Current tax

(83)

(1,180)

(1,130)

Deferred tax

(230)

(688)

(6,074)

 

(313)

(1,868)

(7,204)

Total:

 

 

 

Current tax

1,621

1,300

3,418

Deferred tax

835

 (79)

(4,664)

Total tax charge/(credit)

2,456

1,221

(1,246)

 

 

7. Dividends

 

 

Six months

Six months

Year

 

ended

ended

ended

 

30 June

30 June

31 December

 

2010

2009

2009

 

£000

£000

£000

Equity dividends on ordinary shares:

 

 

 

Final dividend for the year ended 2008 - 2.0 pence

-

4,081

4,081

Interim dividend for the year ended 2009 - 0.75 pence

-

-

1,527

Final dividend for the year ended 2009 - 2.15 pence

4,802

-

-

 

4,802

4,081

5,608

 

The final dividend for the year ended 31 December 2009 of 2.15 pence per share was approved by shareholders at the Annual General Meeting on 13 May 2010 and was paid on 2 July 2010. This dividend is included in trade and other payables at 30 June 2010.

 

The proposed 2010 interim dividend of 0.9 pence per share was approved by the Board on 25 August 2010 and in accordance with IFRS has not been included as a deduction from equity at 30 June 2010. The dividend will be paid on 5 November 2010 to those shareholders on the register on 1 October 2010.

 

8. Earnings per share

The data used in the calculation of the earnings per share numbers is summarised in the table below:

 

Six months ended

 

Six months ended

 

Year ended

 

30 June 2010

 

30 June 2009

 

31 December 2009

 

 

Weighted

 

Weighted

 

Weighted

 

average number

 

average number

 

average number

 

Earnings

£000

of shares

000's

Earnings

£000

of shares

000's

Earnings

£000

of shares

000's

Basic

7,079

236,938

193

205,670

(8,648)

208,335

Diluted

7,079

245,903

193

209,383

(8,648)

208,335*

Adjusted basic

9,228

236,938

7,833

205,670

17,128

208,335

Adjusted diluted

9,228

245,903

7,833

209,383

17,128

214,821

 

*Because basic EPS results in a loss per share the diluted EPS is calculated using the undiluted weighted average number of shares.

 

The basic earnings per share calculation is based on the profit/(loss) for the period attributable to parent company shareholders divided by the weighted average number of ordinary shares outstanding during the period.

 

Diluted earnings per share is calculated based on the profit/(loss) for the period attributable to parent company shareholders divided by the weighted average number of ordinary shares outstanding during the period adjusted for the potentially dilutive impact of employee share option schemes.

 

Adjusted earnings per share is calculated in order to provide information to shareholders about continuing trading performance and is based on the profit attributable to parent company shareholders excluding highlighted items together with related tax effects as set out below:

 

 

Six months

Six months

Year

 

ended

ended

ended

 

30 June

30 June

31 December

 

2010

2009

2009

 

£000

£000

£000

Earnings:

 

 

 

Profit/(loss) for the period attributable to the Parent Company's shareholders

7,079

193

(8,648)

Highlighted items (net of tax) attributable to the Parent Company's shareholders

2,149

7,640

25,776

Adjusted earnings

9,228

7,833

17,128

 

 

9. Intangible assets

 

 

Brands

Customer relationships

Goodwill

Software development costs

Total

 

£000

£000

£000

£000

£000

Cost

 

 

 

 

 

At 1 January 2010

25,074

27,325

289,429

432

342,260

Adjustments to prior year acquisitions

-

-

513

-

513

Capitalised development costs

-

-

-

90

90

Exchange differences

326

836

3,459

-

4,621

At 30 June 2010

25,400

28,161

293,401

522

347,484

Amortisation and impairment charges

 

 

 

 

At 1 January 2010

17,397

19,019

18,453

127

54,996

Charge for the period

374

2,089

-

76

2,539

Exchange differences

269

315

(866)

(12)

(294)

At 30 June 2010

18,040

21,423

17,587

191

57,241

Net book value at 30 June 2010

7,360

6,738

275,814

331

290,243

Net book value at 31 December 2009

7,677

8,306

270,976

305

287,264

 

Brands and customer relationships are being amortised over their useful economic lives of between 3 and 20 years.

 

Adjustments to acquisitions completed prior to 31 December 2009 comprise changes to estimated contingent deferred consideration and costs of acquisition.

 

 

 

10. Cash flow analysis

(a) Reconciliation of operating profit to net cash inflow from operations

 

 

Six months

Six months

Year

 

ended

ended

ended

 

30 June

 30 June

31 December

 

2010

2009

 2009

 

£000

£000

£000

Operating profit/(loss)

11,166

2,554

(7,909)

Depreciation

1,169

1,269

2,547

Share option charge

199

1,171

2,005

(Profit)/loss on disposal of property, plant and equipment

(5)

1

(34)

Amortisation of intangible assets

2,539

2,432

4,879

Impairment of intangible assets

-

-

9,141

Expense incurred on hedging activities

273

-

497

Unrealised foreign exchange gain

(129)

-

-

Loss on disposal of subsidiaries

-

140

7,527

Increase in work in progress

(364)

 (68)

(184)

Decrease in debtors

2,551

 2,095

818

Decrease in creditors

(9,542)

(6,798)

(318)

Decrease in provisions

(2,387)

 (200)

(1,007)

Net cash inflow from operations

5,470

2,596

17,962

 

 

Net cash inflow from operations is analysed as follows:

 

Six months

Six months

Year

 

ended

ended

ended

 

30 June

 30 June

31 December

 

2010

2009

 2009

 

£000

£000

£000

Before highlighted items

8,522

7,764

28,450

Highlighted items

(3,052)

(5,168)

(10,488)

Net cash inflow from operations

5,470

2,596

17,962

 

Of the 2010 highlighted cash flows, £1.3 million relates to the cash impact of property provisions made in prior periods and £1.7 million is in respect of brand rationalisation provided for in the prior year.

  

10. Cash flow analysis (continued)

 (b) Reconciliation of net cash flow to movement in net debt

 

 

Six months

Six months

Year

 

ended

ended

 ended

 

 30 June

 30 June

31 December

 

2010

2009

 2009

 

£000

£000

£000

Decrease in cash and cash equivalents in the period

(987)

 (4,710)

(3,142)

Cash inflow from debt drawdowns

(5,395)

 (49)

(4,654)

Bank loans acquired

-

-

(6,558)

Settlement of derivative financial instruments

(277)

444

497

Repayment of capital element of finance leases

38

24

151

Change in net debt resulting from cash flows

(6,621)

 (4,291)

(13,706)

Amortisation of loan fees

(74)

(72)

(81)

Movement in fair value of derivative financial instruments

(433)

(65)

(438)

Acquisition of finance leases

(39)

-

9

Translation differences

284

 (1,966)

(1,317)

Increase in net debt

(6,883)

 (6,394)

(15,533)

Net debt at beginning of period

(49,033)

 (33,500)

(33,500)

Net debt at end of period

(55,916)

 (39,894)

(49,033)

 

(c) Analysis of net debt

 

 

30 June

30 June

31 December

 

2010

2009

2009

 

£000

£000

£000

Cash and short-term deposits

8,731

6,848

9,394

Overdrafts (current)

(4)

(11)

(23)

Net cash and cash equivalents

8,727

6,837

9,371

Bank loans (current)

(3,000)

-

(3,000)

Bank loans and overdrafts (non-current)

(60,068)

(46,071)

(54,550)

Derivative financial assets

163

462

375

Derivative financial liabilities

(1,581)

(849)

(1,082)

Obligations under finance leases

(157)

(273)

(147)

Net debt

(55,916)

(39,894)

(49,033)

 

(d) Cash and cash equivalents

 

 

 

 

 

 

 

 

 

 

30 June

 30 June

 31 December

 

2010

2009

 2009

 

£000

£000

£000

Cash and short-term deposits

8,731

6,848

9,394

Overdrafts (current)

(4)

 (11)

(23)

Cash and cash equivalents

8,727

6,837

9,371

 

 

11. related party transactions

The ultimate controlling party of the Group is Huntsworth plc (incorporated in the United Kingdom). The Group has a related party relationship with its associates and with Directors and executive officers. There were no material related party transactions other than the remuneration of key management personnel in the six months ended 30 June 2010.

 

 

12. POST BALANCE SHEET EVENTS

On 9 July 2010, the Group acquired the entire share capital of ScopeMedical Limited, a company incorporated in the UK. The initial cash consideration was £4.6 million of which £0.7 million is deferred for 12 months. Additional consideration is payable dependent on future performance during the period to 31 December 2013 and will be paid in cash or a combination of cash and shares at Huntsworth's discretion. The maximum total consideration payable is £11 million. As at the date of this report, it is impracticable to determine the fair values of the assets and liabilities acquired and the goodwill recognised.

 

Independent Review Report

To the Board of Huntsworth plc

Introduction

We have been engaged by the Company to review the condensed set of financial statements in the half-yearly financial report for the six months ended 30 June 2010 which comprises the Consolidated Income Statement, the Consolidated Statement of Comprehensive Income, the Consolidated Balance Sheet, the Consolidated Statement of Cash Flows, the Consolidated Statement of Changes in Equity and the related notes 1 to 12. We have read the other information contained in the half yearly financial report and considered whether it contains any apparent misstatements or material inconsistencies with the information in the condensed set of financial statements.

This report is made solely to the company in accordance with guidance contained in International Standard on Review Engagements 2410 (UK and Ireland) "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Auditing Practices Board. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company, for our work, for this report, or for the conclusions we have formed.

 

Directors' Responsibilities

The half-yearly financial report is the responsibility of, and has been approved by, the directors. The directors are responsible for preparing the half-yearly financial report in accordance with the Disclosure and Transparency Rules of the United Kingdom's Financial Services Authority.

As disclosed in note 1, the annual financial statements of the group are prepared in accordance with IFRSs as adopted by the European Union. The condensed set of financial statements included in this half-yearly financial report has been prepared in accordance with International Accounting Standard 34, "Interim Financial Reporting", as adopted by the European Union.

 

Our Responsibility

Our responsibility is to express to the Company a conclusion on the condensed set of financial statements in the half-yearly financial report based on our review.

 

Scope of Review

We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Auditing Practices Board for use in the United Kingdom. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK and Ireland) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

 

Conclusion

Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the half-yearly financial report for the six months ended 30 June 2010 is not prepared, in all material respects, in accordance with International Accounting Standard 34 as adopted by the European Union and the Disclosure and Transparency Rules of the United Kingdom's Financial Services Authority.

 

Ernst & Young LLP

London

26 August 2010

 

 

Statement of Directors' Responsibilities

for the six months ended 30 June 2010

We confirm that to the best of our knowledge this interim report:

 

- has been prepared in accordance with IAS 34 'Interim Financial Reporting' as adopted by the European Union;

 - includes a fair review of the information required by the Financial Services Authority's Disclosure and Transparency Rules ('DTR') 4.2.7R (indication of important events during the first six months and description of principal risks and uncertainties for the remaining six months of the year); and

 

- includes a fair review of the information required by DTR 4.2.8R (disclosure of related party transactions and changes

therein).

By order of the Board

 

 

 Sally Withey

 Chief Operating Officer

 Tymon Broadhead

 Group Finance Director

 26 August 2010

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR EANPSAAAEEFF

Related Shares:

HNT.L
FTSE 100 Latest
Value8,275.66
Change0.00